A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment - Taylor, Lesley; Crockett, Julie; Tayo, Bola; Morrison, Gilmour (Journal of clinical pharmacology, 2019)
Keywords: cannabidiol; cannabinoid; hepatic impairment; liver function; pharmacokinetic; cannabidiol; hepatic impairment; pharmacokinetic; cannabinoid; liver function